Literature DB >> 15279960

Inhibitory and neutral antibodies to Plasmodium falciparum MSP119 form ring structures with their antigen.

Carien Dekker1, Chairat Uthaipibull, Lesley J Calder, Matthew Lock, Munira Grainger, William D Morgan, Guy G Dodson, Anthony A Holder.   

Abstract

Blood-stage malaria vaccine candidates include surface proteins of the merozoite. Antibodies to these proteins may either block essential steps during invasion or render the merozoite susceptible to phagocytosis or complement-mediated degradation. Structural information on merozoite surface proteins complexed to antibodies provides crucial information for knowledge-based vaccine design. The major merozoite surface protein MSP1 is an abundant surface molecule in Plasmodium falciparum. Only a subset of antibodies against MSP119 inhibits invasion (inhibitory antibodies), whereas other antibodies binding to MSP119 have no effect on invasion (neutral antibodies). Here we report on the complex of MSP119 with both inhibitory monoclonal antibody 12.10 and neutral monoclonal antibody 2F10. The complexes were established using both whole IgG's and Fab fragments, and analysed by dynamic light scattering, electron microscopy and analytical ultra centrifugation. Specific ring structures were formed in the ternary complex with the two antibodies, providing direct evidence of non-overlapping epitopes on MSP119. Mutational studies also indicated that the epitopes of the inhibitory and neutral antibodies are spatially remote.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15279960     DOI: 10.1016/j.molbiopara.2004.05.008

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  8 in total

1.  Inhibitory antibodies specific for the 19-kilodalton fragment of merozoite surface protein 1 do not correlate with delayed appearance of infection with Plasmodium falciparum in semi-immune individuals in Vietnam.

Authors:  E Elsa Herdiana Murhandarwati; Lina Wang; Casilda G Black; Doan Hanh Nhan; Thomas L Richie; Ross L Coppel
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

2.  Modification of a human monoclonal antibody Fab fragment specific for Plasmodium falciparum 19-kDa C-terminal merozoite surface protein 1 by site-directed mutagenesis.

Authors:  Yan-Lin Tao; Xun-Jia Cheng; Yong-Feng Fu; Hideo Tsukamoto; Eisaku Yoshihara; Hiroshi Tachibana
Journal:  Parasitol Res       Date:  2008-04-30       Impact factor: 2.289

3.  IgG isotype to C-terminal 19 kDa of Plasmodium vivax merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil.

Authors:  Cristiane G Morais; Irene S Soares; Luzia H Carvalho; Cor Jesus F Fontes; Antoniana U Krettli; Erika Martins Braga
Journal:  Parasitol Res       Date:  2005-03-10       Impact factor: 2.289

4.  Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum.

Authors:  Changling Li; Rui Wang; Yuan Wu; Dongmei Zhang; Zhicheng He; Weiqing Pan
Journal:  Malar J       Date:  2010-04-12       Impact factor: 2.979

5.  Inhibition of erythrocyte invasion and Plasmodium falciparum merozoite surface protein 1 processing by human immunoglobulin G1 (IgG1) and IgG3 antibodies.

Authors:  Maria Lazarou; José A Guevara Patiño; Richard M Jennings; Richard S McIntosh; Jianguo Shi; Steven Howell; Eilish Cullen; Tarran Jones; Jaime R Adame-Gallegos; Jonathan A Chappel; Jana S McBride; Michael J Blackman; Anthony A Holder; Richard J Pleass
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

6.  Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1.

Authors:  Bart W Faber; Edmond J Remarque; William D Morgan; Clemens H M Kocken; Anthony A Holder; Alan W Thomas
Journal:  Infect Immun       Date:  2007-10-15       Impact factor: 3.441

7.  Inhibition of parasite invasion by monoclonal antibody against epidermal growth factor-like domain of Plasmodium vivax merozoite surface protein 1 paralog.

Authors:  Jin-Hee Han; Yang Cheng; Fauzi Muh; Md Atique Ahmed; Jee-Sun Cho; Myat Htut Nyunt; Hye-Yoon Jeon; Kwon-Soo Ha; Sunghun Na; Won Sun Park; Seok-Ho Hong; Ho-Joon Shin; Bruce Russell; Eun-Taek Han
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

8.  Cellular responses to modified Plasmodium falciparum MSP119 antigens in individuals previously exposed to natural malaria infection.

Authors:  Christian M F Okafor; Chiaka I Anumudu; Yusuf O Omosun; Chairat Uthaipibull; Idowu Ayede; Henrietta O Awobode; Alex B Odaibo; Jean Langhorne; Anthony A Holder; Roseangela I Nwuba; Marita Troye-Blomberg
Journal:  Malar J       Date:  2009-11-23       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.